Cargando…
Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients
Multiple sclerosis (MS) is an immune system-mediated neurodegenerative disease. Recent studies suggest that viral agents, especially the Epstein Barr virus (EBV), are etiological agents for MS. The roles of other viruses in MS have been investigated. Studies have shown an increase in the level of an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282537/ https://www.ncbi.nlm.nih.gov/pubmed/37351152 http://dx.doi.org/10.1016/j.ijregi.2023.04.002 |
_version_ | 1785061155164651520 |
---|---|
author | Jeda, Ali Salimi Zarei, Anna Ghabeshi, Soad Tabibzadeh, Alireza Lotfi, Mohsen Etemadifar, Masoud Niya, Mohammad Hadi Karbalaie Ghorbanlou, Mehrdad Esghaei, Maryam |
author_facet | Jeda, Ali Salimi Zarei, Anna Ghabeshi, Soad Tabibzadeh, Alireza Lotfi, Mohsen Etemadifar, Masoud Niya, Mohammad Hadi Karbalaie Ghorbanlou, Mehrdad Esghaei, Maryam |
author_sort | Jeda, Ali Salimi |
collection | PubMed |
description | Multiple sclerosis (MS) is an immune system-mediated neurodegenerative disease. Recent studies suggest that viral agents, especially the Epstein Barr virus (EBV), are etiological agents for MS. The roles of other viruses in MS have been investigated. Studies have shown an increase in the level of antibodies against bovine leukemia virus (BLV) in patients with MS. In this regard, our study aimed to examine the presence of BLV DNA in peripheral blood mononuclear cells (PBMCs) of MS patients in Iran. In this cross-sectional study, the presence of BLV in 109 Iranian MS patients and 60 healthy controls was evaluated. The isolated PBMCs were used for DNA extraction and PCR, using specific primers for two distinct genes. The mean age of the participants was 39 ± 9.5 years, and 27 (24.77%) of them were male. Clinical evaluation of these patients showed the most frequent MS type to be relapsing-remitting MS (RRMS) (71; 65.14%). BLV evaluation did not show any BLV DNA presence in the PBMCs of individuals in either the MS or healthy control groups. Therefore, our study showed no evidence of BLV infection in Iranian MS patients. |
format | Online Article Text |
id | pubmed-10282537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102825372023-06-22 Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients Jeda, Ali Salimi Zarei, Anna Ghabeshi, Soad Tabibzadeh, Alireza Lotfi, Mohsen Etemadifar, Masoud Niya, Mohammad Hadi Karbalaie Ghorbanlou, Mehrdad Esghaei, Maryam IJID Reg Short Communication Multiple sclerosis (MS) is an immune system-mediated neurodegenerative disease. Recent studies suggest that viral agents, especially the Epstein Barr virus (EBV), are etiological agents for MS. The roles of other viruses in MS have been investigated. Studies have shown an increase in the level of antibodies against bovine leukemia virus (BLV) in patients with MS. In this regard, our study aimed to examine the presence of BLV DNA in peripheral blood mononuclear cells (PBMCs) of MS patients in Iran. In this cross-sectional study, the presence of BLV in 109 Iranian MS patients and 60 healthy controls was evaluated. The isolated PBMCs were used for DNA extraction and PCR, using specific primers for two distinct genes. The mean age of the participants was 39 ± 9.5 years, and 27 (24.77%) of them were male. Clinical evaluation of these patients showed the most frequent MS type to be relapsing-remitting MS (RRMS) (71; 65.14%). BLV evaluation did not show any BLV DNA presence in the PBMCs of individuals in either the MS or healthy control groups. Therefore, our study showed no evidence of BLV infection in Iranian MS patients. Elsevier 2023-04-06 /pmc/articles/PMC10282537/ /pubmed/37351152 http://dx.doi.org/10.1016/j.ijregi.2023.04.002 Text en © 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Communication Jeda, Ali Salimi Zarei, Anna Ghabeshi, Soad Tabibzadeh, Alireza Lotfi, Mohsen Etemadifar, Masoud Niya, Mohammad Hadi Karbalaie Ghorbanlou, Mehrdad Esghaei, Maryam Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients |
title | Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients |
title_full | Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients |
title_fullStr | Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients |
title_full_unstemmed | Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients |
title_short | Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients |
title_sort | evaluation of the prevalence of bovine leukemia virus dna in peripheral blood mononuclear cells of multiple sclerosis patients |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282537/ https://www.ncbi.nlm.nih.gov/pubmed/37351152 http://dx.doi.org/10.1016/j.ijregi.2023.04.002 |
work_keys_str_mv | AT jedaalisalimi evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT zareianna evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT ghabeshisoad evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT tabibzadehalireza evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT lotfimohsen evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT etemadifarmasoud evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT niyamohammadhadikarbalaie evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT ghorbanloumehrdad evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients AT esghaeimaryam evaluationoftheprevalenceofbovineleukemiavirusdnainperipheralbloodmononuclearcellsofmultiplesclerosispatients |